table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderateCOVID-19 severe or critically
COVID 19 hospitalizedCOVID-19 mild to moderateCOVID-19 severe or critically
interferon
IFN beta-1a SOLIDARITY ... Darazam ... Kalil ...
high-dose IFN beta-1a Darazam
IFN beta-1b Darazam ... Rahmani
inhaled interferon
IFN alpha
pegylated interferon-α2b Pandit Shashi Bhushan
recombinant super-compound interferon rSIFN-co Li
SNG001 inhaled interferon beta Synairgen SG016
interferon / TFF2 Fu
peginterferon Jagannathan
PNB001 Lattmann

7 studies excluded by filtering options 0

4861 Cai -FAVIPIRAVIR, 2020 1310not a RCTrisk of bias not avaialble
5183 Qiong Zhou, 2020 0190selection pending
5402 Davoudi-Monfared, 2020 113high risk of bias
5534 Wang (early IFN), 2020 0134selection pending
5553 Esquivel-Moynelo, 2020 113high risk of bias
5572 Hao, 2020 0200selection pending
6140 Wang, 2020 0130selection pending

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons